arrow
Y

Yolanda Ruano

Hospital Universitario Ramón y Cajal
H指数:18
被引数:1,186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy analysis of CDK4/6 inhibitors in combination with endocrine therapy treatment in HR+/HER2-breast cancer according to PAM50 intrinsic subtype: primary results of SOLTI-1801_CDK-PREDICT study
2023-03-010
PRE
Solti-1801. Analysis of the efficacy of CDK4/6 inhibitors in combination with hormonal treatment in luminal breast cancer in relation to the intrinsic subtype and markers of immunity (CDK-predict)
2022-02-151
PRE
CDK4/6 inhibition and endocrine therapy (ET) in the HER2-enriched subtype (HER2-E) in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer (ABC): A retrospective analysis of real-world data
2021-05-012
OA
TERT promoter mutation in sebaceous neoplasms
2021-03-256
PRE
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)
2020-10-0614
PREAI
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation (vol 216, pg 1061, 2019)

使用来自淋巴引流的细胞外囊泡作为黑色素瘤进展和BRAFV600E突变的替代标志物 (216卷,1061页,2019页)

2019-04-226
OAAI
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation
2019-04-11108
OAAI